BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas.
You G, Feng L, Yan W, Zhang W, Wang YZ, Li SW, Li SW, Li GL, Song YJ, Kang CS, You YP, Jiang T.
You G, et al. Among authors: li sw, li gl.
CNS Neurosci Ther. 2013 Nov;19(11):882-8. doi: 10.1111/cns.12148. Epub 2013 Jul 10.
CNS Neurosci Ther. 2013.
PMID: 23841872
Free PMC article.
Clinical Trial.